DECIPHER: improving genetic diagnosis through dynamic integration of genomic and clinical data

J Foreman, D Perrett, E Mazaika… - Annual review of …, 2023 - annualreviews.org
DECIPHER (D atabas e of Genomi c Var i ation and P henotype in H umans Using E nsembl
R esources) shares candidate diagnostic variants and phenotypic data from patients with …

[HTML][HTML] Shared genetic predisposition in peripartum and dilated cardiomyopathies

JS Ware, J Li, E Mazaika, CM Yasso… - … England Journal of …, 2016 - Mass Medical Soc
Background Peripartum cardiomyopathy shares some clinical features with idiopathic
dilated cardiomyopathy, a disorder caused by mutations in more than 40 genes, including …

Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome …

JT Glessner, AG Bick, K Ito, JG Homsy… - Circulation …, 2014 - Am Heart Assoc
Rationale: Congenital heart disease (CHD) is among the most common birth defects. Most
cases are of unknown pathogenesis. Objective: To determine the contribution of de novo …

Genetic variants associated with cancer therapy–induced cardiomyopathy

P Garcia-Pavia, Y Kim, MA Restrepo-Cordoba… - Circulation, 2019 - Am Heart Assoc
Background: Cancer therapy–induced cardiomyopathy (CCM) is associated with cumulative
drug exposures and preexisting cardiovascular disorders. These parameters incompletely …

Reevaluating the genetic contribution of monogenic dilated cardiomyopathy

F Mazzarotto, U Tayal, RJ Buchan, W Midwinter… - Circulation, 2020 - Am Heart Assoc
Background: Dilated cardiomyopathy (DCM) is genetically heterogeneous, with> 100
purported disease genes tested in clinical laboratories. However, many genes were …

Digital droplet PCR: CNV analysis and other applications

E Mazaika, J Homsy - Current protocols in human genetics, 2014 - Wiley Online Library
Digital droplet PCR (ddPCR) is an assay that combines state‐of‐the‐art microfluidics
technology with TaqMan‐based PCR to achieve precise target DNA quantification at high …

[HTML][HTML] Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic …

R Walsh, F Mazzarotto, N Whiffin, R Buchan… - Genome medicine, 2019 - Springer
Background International guidelines for variant interpretation in Mendelian disease set
stringent criteria to report a variant as (likely) pathogenic, prioritising control of false-positive …

Nationwide Study on Hypertrophic Cardiomyopathy in Iceland: Evidence of a MYBPC3 Founder Mutation

B Adalsteinsdottir, P Teekakirikul, BJ Maron… - Circulation, 2014 - Am Heart Assoc
Background—The geographic isolation and homogeneous population of Iceland are ideally
suited to ascertain clinical and genetic characteristics of hypertrophic cardiomyopathy …

[HTML][HTML] Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions

X Zhang, R Walsh, N Whiffin, R Buchan… - Genetics in …, 2021 - nature.com
Purpose Accurate discrimination of benign and pathogenic rare variation remains a priority
for clinical genome interpretation. State-of-the-art machine learning variant prioritization …

[PDF][PDF] The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings

KA McGurk, X Zhang, P Theotokis, K Thomson… - The American Journal of …, 2023 - cell.com
Understanding the penetrance of pathogenic variants identified as secondary findings (SFs)
is of paramount importance with the growing availability of genetic testing. We estimated …